Business Wire

Nexcelom Bioscience Expands Automated Cell Counting Product Offerings with Launch of Cellometer ® Auto X4

LAWRENCE, Mass.--(BUSINESS WIRE)--Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced it continues to ...
technologynetworks

Nexcelom Bioscience Extends Automated Cell Counting Product Platform with Launch of Cellometer® Auto M10™

Nexcelom Bioscience LLC has announced it has extended its product platform with the launch of the Cellometer Auto M10™ automatic cell counter. The Auto M10 maintains the user benefits of the ...
technologynetworks

Nexcelom Bioscience Adds User-Changeable Fluorescence Optics Modules to Cellometer Vision

Nexcelom Bioscience LLC, has announced a major enhancement - the addition of user-changeable fluorescence optics modules - to Cellometer® Vision, its automated fluorescence-based imaging cell counter ...
PE Hub

Ampersand sells Nexcelom Bioscience for $260m

Ampersand Capital Partners has sold Nexcelom Bioscience to PerkinElmer for $260 million. Based in Lawrence, Massachusetts, Nexcelom is a provider of automated cell counting solutions. WELLESLEY, Mass.